FDA makes management changes

Former Dartmouth Medical School dean Stephen Spielberg has been named the deputy commissioner for medical products and tobacco, a newly-created position at the FDA. In a letter, Commissioner Margaret Hamburg said the reorganization "more accurately reflect the agency's responsibilities, subject matter expertise and mandates in an ever more complex world, where products and services do not fit into a single category." Spielberg will oversee for drugs, medical devices, biological products and tobacco. Additionally, current CDER Office of Compliance director Deborah Autor will become Deputy Commissioner for Global Regulatory Operations and Policy. She'll be tasked with addressing global regulatory issues. Article | Report

Suggested Articles

Omega Therapeutics is working on treatments that adjust gene expression up or down without making permanent changes to the genome.

The IPO window is still wide open for biotech, and French Big Pharma-partnered Innate is looking to jump right on through.

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.